Corrigendum to “Rational approach to drug discovery for human schistosomiasis” [Int. J. Parasitol. Drugs Drug Resist. 16 (2021) 140–147] (International Journal for Parasitology: Drugs and Drug Resistance (2021) 16 (140–147), (S221132072100021X), (10.1016/j.ijpddr.2021.05.002))

Philip T. LoVerde, Sevan N. Alwan, Alexander B. Taylor, Jayce Rhodes, Frédéric D. Chevalier, Timothy Jc Anderson, Stanton F. McHardy

Resultado de la investigación: Comment/debaterevisión exhaustiva

Resumen

The authors regret that the acknowledgements of SNA were funded by SABER IRACDA program 2k12GM111726 was inadvertently left out of the article.

Idioma originalEnglish (US)
Páginas (desde-hasta)103
Número de páginas1
PublicaciónInternational Journal for Parasitology: Drugs and Drug Resistance
Volumen18
DOI
EstadoPublished - abr 2022
Publicado de forma externa

ASJC Scopus subject areas

  • Parasitology
  • Infectious Diseases
  • Pharmacology (medical)

Huella

Profundice en los temas de investigación de 'Corrigendum to “Rational approach to drug discovery for human schistosomiasis” [Int. J. Parasitol. Drugs Drug Resist. 16 (2021) 140–147] (International Journal for Parasitology: Drugs and Drug Resistance (2021) 16 (140–147), (S221132072100021X), (10.1016/j.ijpddr.2021.05.002))'. En conjunto forman una huella única.

Citar esto